Articles in section Licensing
| << Joint Venture | 505 articles | Mergers & Acquisitions >> |
| << Previous | Pages 1 ..4 5 6 7 8 9 .. 51 | Next >> |
-
Five Prime Signs US$530 M Licensing Deal with Seattle Genetics
-
Gilead Collaborates with Kyverna Therapeutics on T-cell Therapies
-
Pfizer Licenses eFFECTOR's eIF4E Inhibitors to Bolster Oncology Pipeline
-
Roche In-licenses Amunix’s Half-life Extension Technology in US$1.5 B Deal
-
Boehringer Ingelheim Buys Rights to Enleofen’s Fibro-inflammatory Anti-IL-11 Platform
-
Roche Licenses Sarepta’s DMD Therapy for US$2.88 B
-
Jazz Pharmaceuticals Licenses PharmaMar’s Lung Cancer Drug Lurbinectedin
-
Allergan Continues to Grow Medical Aesthetics Franchise with Exicure Deal
-
Ipsen Boosts Rare Disease Portfolio with Blueprint’s BLU-782
-
Takeda Bolsters IBD Pipeline by Partnering with Prometheus Biosciences
RSS